---
$id: https://graph.org.ai/products/commodity/51282918
$type: Product
source: UNSPSC
code: "51282918"
title: "Fleroxacin"
class: "51282900"
classTitle: "Quinolone antibacterials"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Fleroxacin

**UNSPSC Code**: 51282918
**Class**: [Quinolone antibacterials](Quinolone antibacterials.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a quinolone antibiotic with the molecular formula C17H18F3N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N804LDH51K, chemically known as 6,8-difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methylpiperazino)-4-oxo-3-quinolinecarboxylic acid but generally known as fleroxacin, which bears US NIH Compound Identifier 3357. European Medicines Agency schedules Fleroxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07639MIG. The term FLEROXACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). World Health Organization schedules fleroxacin in its Anatomical Therapeutic Chemical (ATC) Classification. FLEROXACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fleroxacin under HS 29335995 and SITC 51576. As of Q4 2014, FLEROXACIN remains the US FDA Preferred Term for this commodity. Fleroxacin bears US NLM identifiers UMLS ID C0085161 and NCI Concept Code C72657. SMILES: FC1C(N2CCN(CC2)C)C(F)CC2C1N(CCF)CC(C2=O)C(=O)O.

